Dizziness Handicap Inventory, Vestibular Disorders Activities of Daily Living Scale scores improved for those with, without migraine
TUESDAY, Dec. 7, 2021 (HealthDay News) — For patients with vestibular migraine or nonmigraine vestibular dysfunction, vestibular rehabilitation (VR) might help reduce symptoms and improve quality of life, according to a study recently published in the Brazilian Journal of Otorhinolaryngology.
Ahmet Koc, from the Acıbadem Mehmet Ali Aydınlar University, and Elvan Cevizci Akkılıc, M.D., from the Acıbadem Kozyatagı Hospital, both in Istanbul, Turkey, examined the effects of VR for vestibular symptoms and quality of life in patients with vestibular migraine or nonmigraine vestibular dysfunction (30 participants in each group). Patients received 18 sessions of VR during 1.5 months.
The researchers found that the Dizziness Handicap Inventory score, Vestibular Disorders Activities of Daily Living Scale scores, and frequency of dizziness and headache scores were significantly improved with VR in both the vestibular migraine group and the vestibular dysfunction group. Both patient groups had higher posttreatment versus pretreatment scores for Computerized Dynamic Posturography results.
“In patients with vestibular problems with or without migraine who underwent VR, a significant improvement was observed in subjective and objective balance assessment measurements after treatment,” the authors write. “VR must be considered in patients who do not benefit from medical therapy or have limited benefit.”
Updated Recommendations Address Medications to Prevent Migraine in Adults
Botox Helpful in Alleviating Chronic Migraine in Pediatric Patients
Vestibular Rehab Important for Acute Vertigo, Regardless of Delivery Mode
Contralateral Endolymphatic Hydrops ID"d in One in Four Patients With Unilateral Meniere Disease
Voice Disorders Linked to Elevated Risk for Incident Cognitive Decline
Brain Abnormalities Identified in Children at Risk for Schizophrenia
Cortical Atrophy in Early-Onset Alzheimer Disease Signature Can Predict Progression to Dementia
Imaging Turnaround Time Increased From 2023 to 2024